loading

Dyne Therapeutics Inc Aktie (DYN) Neueste Nachrichten

pulisher
05:27 AM

How many analysts rate Dyne Therapeutics Inc. as a “Buy”Market Forecast Recommendation With Low Risk - jammulinksnews.com

05:27 AM
pulisher
12:08 PM

Dyne Therapeutics Advances in Neuromuscular Therapies - TipRanks

12:08 PM
pulisher
Jul 28, 2025

Dyne Therapeutics Narrowed Its Loss And Won Analyst Support - Finimize

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne Therapeutics extends cash runway as it advances key drug programs - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne Therapeutics, Inc. Q2 Loss Increases, Misses Estimates - Nasdaq

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne (DYN) Expects Funding to Sustain Operations Through 2027 - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne (DYN) Advances Clinical Programs and Strengthens Financial Position - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne Therapeutics Extends Cash Runway to Q3 2027, Advances Clinical Trials for DM1 and DMD - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights | DYN Stock News - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Dyne Therapeutics Inc. stockOutstanding capital appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Dyne Therapeutics Inc. stockDiscover breakthrough investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Dyne Therapeutics Inc. stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Dyne Therapeutics Inc. company’s growth strategyDiscover market opportunities with expert help - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Dyne Therapeutics Inc. stock in 2025Breakthrough investment results - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Dyne Therapeutics Inc. stock price move sharplyRecord-setting profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Dyne Therapeutics Inc. in the next 12 monthsGet insider insights into market trends - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Dyne Therapeutics Inc.Track emerging stocks with high growth potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - WV News

Jul 27, 2025
pulisher
Jul 24, 2025

Dyne Therapeutics Inc. Stock Analysis and ForecastBreakout profit opportunities - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Dyne Therapeutics Inc. stockFree Stock Market Return Analysis - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Dyne Therapeutics Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Is Dyne Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Dyne Therapeutics (NASDAQ:DYN) Price Target Lowered to $9.00 at JPMorgan Chase & Co. - MarketBeat

Jul 18, 2025
pulisher
Jul 16, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Ray Dalio, Scott Bessent, Elliott Management, Citadel Investment Group, Balyasny Asset Management, Qualys Inc (QLYS), Dyne Therapeutics Inc (DYN), and More - Insider Monkey

Jul 16, 2025
pulisher
Jul 16, 2025

Dyne Therapeutics (DYN) Stock Rises as CEO Increases Stake - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Dyne shares up after CEO buys stock (DYN:NASDAQ) - Seeking Alpha

Jul 16, 2025
pulisher
Jul 16, 2025

Former Biogen VP Who Led SPINRAZA Success Joins Satellos to Advance DMD Treatment - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

Strategic Confidence in Dyne Therapeutics: Insider Backing and Breakthroughs in Rare Disease Therapies - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

DYN CEO Makes Significant Stock Purchase, Shares Rise | DYN Stoc - GuruFocus

Jul 15, 2025
$22.71
price down icon 1.65%
$37.35
price up icon 0.57%
$103.69
price up icon 1.82%
$26.84
price down icon 2.22%
$111.16
price down icon 1.27%
biotechnology ONC
$304.48
price up icon 3.22%
Kapitalisierung:     |  Volumen (24h):